Call for Abstracts

15th Annual AACI CRI Meeting Abstracts

This year’s meeting theme will focus on taking innovations in cancer clinical research from abstract to reality. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers.

This year, AACI has changed the abstract submission categories to provide more detail. The seven newly-named categories are:

  1. Community Outreach and Engagement and Diversity, Equity, and Inclusion
  2. Quality Assurance, Remote Monitoring, and Auditing
  3. Regulatory
  4. Resource Management and Finance
  5. Trial Recruitment and Study Conduct
  6. Trial Start-up, Activation, and Protocol Development
  7. Training, Career Development, and Staff Retention

Three abstracts will be selected for oral presentation at the meeting. Up to two authors of each winning abstract will receive a complimentary meeting registration or a refund for a previously paid meeting registration fee. While AACI encourages collaboration with external organizations, only employees of AACI member cancer centers are eligible for complimentary meeting registration. All accepted abstracts will have the opportunity to submit a poster, which will be on display during the poster session for attendees to view and will be featured in the 2023 AACI CRI Abstracts and Posters Book.

The 2023 abstract submission period is now closed.

January 3, 2023
Abstract requirements available

February 1, 2023

Online submission tool opens

March 13, 2023 | 5:00 pm Pacific time
Deadline to submit abstracts

May 2023
Abstracts selected for oral presentation; notifications sent to submitting authors

May 17, 2023 | 5:00 pm Pacific time
Deadline to submit an electronic copy of your poster to [email protected]

Please note: all dates are subject to change.

The abstract's first author must be from an AACI cancer center. Members from more than one center or organization may collaborate. For all authors, please list full first and last names. If the first author and co-author(s) are from different institutions or organizations, please indicate each investigator's institution using a superscript number, as in the example below:

Rachel Jones1; Jill Smith2; Brandon Lee3
1Cancer Center A2Cancer Center B3Cancer Center C  

You must use the AACI CRI abstract template to draft your submission. The abstract word limit is 500 words, not including the abstract title, author and institution names, and abstract template section titles. AACI is providing access to its institutional style guide to help authors standardize the format of all abstracts to simplify their review and publication in CRI's book of abstracts and posters.

Authors will submit abstracts to a specific category. Please select the category that is the best fit for your abstract:
  • Community Outreach and Engagement and Diversity, Equity, and Inclusion
  • Quality Assurance, Remote Monitoring, and Auditing
  • Regulatory
  • Resource Management and Finance
  • Trial Recruitment and Study Conduct
  • Trial Start-up, Activation, and Protocol Development
  • Training, Career Development, and Staff Retention

Note: If a reviewer believes your abstract is better suited for a different category, they may edit this selection.  

You may include one graphic element (photo, illustration, table, or graph, no larger than 4"x6") as an attachment. Please make sure to upload your graphic element as a jpeg file. 
All submitted abstracts should be ready for publication. Please submit your abstract using the online submission tool. If you have any questions, please contact [email protected]
The abstract deadline is 5:00 pm Pacific time on Monday, March 13, 2023.

The abstract template is available in Word or PDF format. Authors are encouraged to submit completed abstracts in Word format.

Why should I submit an abstract? 
An abstract tells a story about how your center has addressed a clinical trials operational problem. Since many AACI cancer centers face similar obstacles, sharing your story helps promote practices leading to better efficiency and quality at other AACI cancer centers.  

Who can submit an abstract?
AACI members may collaborate with other centers or external organizations to submit an abstract.

What should I include in my abstract?
You must use the provided CRI abstract template and describe the following: 

  • Background of the problem 
  • Goals or metrics 
  • Solutions implemented 
  • Results or conclusions from the steps implemented (positive or negative) 
  • Recommendations, lessons learned, or next steps

Do I have to use the AACI CRI abstract template?
It is highly recommended authors use the abstract template, as the template requires the same information that will be collected in the online submission tool. 

May I submit an abstract presented at a past meeting?
Yes. However, if the abstract was submitted for a prior CRI annual meeting, the abstract must be significantly updated from the initial submission. Changes may include project expansion, new or updated results, and/or completion of next steps.

Can I submit an abstract with research that is in progress/interim analysis?
Yes, as with all abstracts, a description of data analysis helps to support your conclusions. However, if you are providing an abstract where the data analysis is not available but other findings can support your solutions and/or lessons learned, the committee is interested in reviewing those abstracts as well.

How do I submit my abstract? 
Beginning in February, authors will be able to enter information online using AACI's submission tool. 

Can I make changes to a submitted abstract?
No. Abstracts will be submitted for review in the format they are received, so please make sure that your abstract is a final version when you submit it to AACI.

Are examples of other CRI meeting abstracts available for review?  
Yes. You may view abstracts and posters from the 14th Annual AACI CRI Meeting in the 2022 Abstracts and Posters Book

How are abstracts scored and selected for presentation?
Abstracts are evaluated by at least two reviewers from the AACI CRI Steering Committee and/or various task force and working group members using a peer-review process. Three abstracts will be chosen for oral presentation that address an issue that provides relevant solutions that can be shared or adapted by other AACI cancer centers.

When will applicants be notified of their review outcome?
Abstract applicants will be notified in May 2023.

What is the size requirement for the poster?
Posters may not exceed 24” x 36” (portrait) or 36” x 24” (landscape).

What format or program should I use to develop my poster?
You may format your poster using a program of your choice. 

Do I need to submit an electronic copy of my poster?
Attendees enjoy viewing posters prior to the meeting. Your poster must be emailed to [email protected] by 5:00 pm Pacific time on Monday, May 15, 2023 for it to be displayed during the meeting. Please email a full-sized, 24” x 36” (portrait) or 36” x 24” (landscape) version of your poster.

Does AACI CRI require a hard copy of my poster?
A hard copy is not required.

How will posters be displayed?
AACI will print and have the posters on display for the start of the meeting. You and/or a co-author will have the opportunity to share your poster with attendees during the Poster Session on Monday, June 26, 2023.

What happens to my poster after the meeting?
Abstracts and posters will be published in a digital book online and distributed in a printed book at the 2023 AACI/CCAF Annual Meeting, which is attended by cancer center directors, administrators, and physician clinical leaders. By submitting an abstract and poster, you give AACI permission to publish these materials. Your abstract will also be available for review on the AACI CRI abstracts and posters webpage for up to one year or until the next AACI CRI Annual Meeting.